Nestle Partners With French Firm To Develop Infant Milk Allergy Test

Nestlé Health Science is partnering with French company DBV Technologies to develop and market a patch-test tool to diagnose cow’s milk protein allergy (CMPA) in infants, a difficult-to diagnose condition that affects as many as three percent of babies. Symptoms of the condition – eczema, reflux, constipation, diarrhea, crying, etc. – often mask CMPA. The new DBV diagnostic tool will be based on its Viaskin technology and will be designed to be ready-to-use and standardized. As a result of the partnership, Nestlé Health Science will have the exclusive worldwide commercialization rights for the tool.